epigenetics
By Dr. Randal S. Olson Whether it’s reducing the time you wait at a traffic light, allowing your phone to respond to your voice, or preventing fraudulent charges to your […]
Read MoreLife Epigenetics, the insurtech subsidiary of GWG Holdings, Inc. (Nasdaq:GWGH), announced that Dr. Randal S. Olson has joined the firm as its Lead Data Scientist. Dr. Olson will bring machine learning, […]
Read More
Don’t count out life insurance as an investment for your clients just yet. According to those who participated in our IRIS.xyz/ETF Trends webinar on Dec. 7, it is an important […]
Read MoreGWG Holdings, Inc. (Nasdaq: GWGH), the parent company of GWG Life, a financial services company committed to transforming the life insurance industry through disruptive and innovative products and services, announced that […]
Read MoreThis is an excerpt from the GWGH 10Q filed Friday: M-Panel Technology Update We recently announced the execution of our exclusive license of “DNA Methylation Based Predictor of Mortality” technology […]
Read MoreIt’s not exactly news that is little truly innovative work going on in the life insurance business, particularly when you compare it to what is taking place in the P&C […]
Read Morehttp://www.lifehealthpro.ca/news/us-insurer-says-new-science-can-predict-life-expectancy-222887.aspx Using the developing science of epigenetics, Minneapolis-based GWG Life is using saliva samples to analyze cells and assess an individual’s risk of all-cause mortality, reported Life Health Professional. The […]
Read MoreMINNEAPOLIS – GWG Life (Nasdaq:GWGH), a financial services company applying epigenetic technology to transform the life insurance industry, announced that it is collecting and analyzing epigenetic samples from life insurance […]
Read More